JP2020510011A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020510011A5 JP2020510011A5 JP2019548370A JP2019548370A JP2020510011A5 JP 2020510011 A5 JP2020510011 A5 JP 2020510011A5 JP 2019548370 A JP2019548370 A JP 2019548370A JP 2019548370 A JP2019548370 A JP 2019548370A JP 2020510011 A5 JP2020510011 A5 JP 2020510011A5
- Authority
- JP
- Japan
- Prior art keywords
- glucocorticoid receptor
- patient
- composition
- composition according
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022070027A JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762469296P | 2017-03-09 | 2017-03-09 | |
| US62/469,296 | 2017-03-09 | ||
| PCT/US2018/021592 WO2018165460A1 (en) | 2017-03-09 | 2018-03-08 | Use of glucocorticoid receptor modulators in the treatment of catecholamine-secreting tumors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070027A Division JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020510011A JP2020510011A (ja) | 2020-04-02 |
| JP2020510011A5 true JP2020510011A5 (cg-RX-API-DMAC7.html) | 2021-02-18 |
| JP7564620B2 JP7564620B2 (ja) | 2024-10-09 |
Family
ID=63446773
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019548370A Active JP7564620B2 (ja) | 2017-03-09 | 2018-03-08 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2022070027A Withdrawn JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A Withdrawn JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A Pending JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022070027A Withdrawn JP2022090003A (ja) | 2017-03-09 | 2022-04-21 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2024053332A Withdrawn JP2024074854A (ja) | 2017-03-09 | 2024-03-28 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
| JP2026061808A Pending JP2026099911A (ja) | 2017-03-09 | 2026-04-03 | カテコールアミン分泌腫瘍の処置における糖質コルチイド受容体モジレータの使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11045482B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3592358A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP7564620B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN110475558A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018230429B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3053806A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MX2019010732A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2018165460A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021007402A (es) | 2018-12-20 | 2021-07-15 | Corcept Therapeutics Inc | Metodos para la toma de imagenes y el tratamiento de tumores positivos para el receptor de somatostatina. |
| JP2021079146A (ja) * | 2021-02-22 | 2021-05-27 | 株式会社三洋物産 | 遊技機 |
| JP7315071B2 (ja) * | 2021-03-03 | 2023-07-26 | 株式会社三洋物産 | 遊技機 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9606736D0 (en) | 1996-02-19 | 1996-06-05 | Shire International Licensing | Therapeutic method |
| CA2246791A1 (en) | 1998-09-01 | 2000-03-01 | Alison Buchan | Treatment of endothelium with somatostatin analogues |
| US6818739B2 (en) | 1999-12-03 | 2004-11-16 | Ndsu Research Foundation | Somatostatins |
| US6139845A (en) | 1999-12-07 | 2000-10-31 | Allergan Sales, Inc. | Method for treating cancer with a neurotoxin |
| JP2004525135A (ja) | 2001-03-23 | 2004-08-19 | コーセプト セラピューティクス, インコーポレイテッド | 糖質コルチコイドレセプター特異的アンタゴニストを使用するストレス障害を処置するための方法 |
| WO2003057214A1 (en) | 2001-12-28 | 2003-07-17 | Somatocor Pharmaceuticals, Inc. | Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
| RU28362U1 (ru) | 2002-12-10 | 2003-03-20 | Закрытое акционерное общество "Дальневосточная технология" | Лист заходной футеровки |
| JP4931794B2 (ja) | 2004-03-09 | 2012-05-16 | コーセプト セラピューティクス, インコーポレイテッド | 縮合環アザデカリン糖質コルチコイド受容体モジュレーター |
| GB0428151D0 (en) * | 2004-12-22 | 2005-01-26 | Novartis Ag | Organic compounds |
| EP2145186A4 (en) * | 2007-05-15 | 2010-10-20 | Water Technologies Corp | DEVICE AND METHOD FOR THE DETECTION OF METANEPHRINES IN PLASMA |
| EP2532350A1 (en) | 2007-10-17 | 2012-12-12 | Laboratoire HRA Pharma | Pharmaceutical combination of a glucocorticoid receptor antagonist and a cortisol synthesis inhibitor for treating cushing's syndrome |
| ES2351569B8 (es) | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
| AU2010247766B2 (en) | 2009-05-12 | 2015-05-21 | Corcept Therapeutics, Inc. | Solid forms and process for preparing |
| WO2011094814A1 (en) * | 2010-02-05 | 2011-08-11 | Phosphagenics Limited | Carrier comprising non-neutralised tocopheryl phosphate |
| CN103596431B (zh) | 2011-03-18 | 2016-06-22 | 科赛普特治疗公司 | 嘧啶环己基糖皮质激素受体调节剂 |
| WO2013039916A1 (en) * | 2011-09-12 | 2013-03-21 | The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services | Compositions for and methods of treatment and enhanced detection of non-pituitary tumors |
| US8859774B2 (en) | 2012-05-25 | 2014-10-14 | Corcept Therapeutics, Inc. | Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators |
| ES2943542T3 (es) | 2013-11-25 | 2023-06-14 | Corcept Therapeutics Inc | Moduladores del receptor de glucocorticoides de azadecalina condensada con octahidro |
| JP6821582B2 (ja) * | 2015-03-02 | 2021-01-27 | コーセプト セラピューティクス, インコーポレイテッド | Acth分泌腫瘍を処置するための糖質コルチコイドレセプターアンタゴニストおよびソマトスタチンアナログの使用 |
| US9943526B2 (en) * | 2015-04-21 | 2018-04-17 | Corcept Therapeutics, Inc. | Optimizing mifepristone levels for cushing's patients |
-
2018
- 2018-03-08 CA CA3053806A patent/CA3053806A1/en active Pending
- 2018-03-08 CN CN201880015928.3A patent/CN110475558A/zh active Pending
- 2018-03-08 WO PCT/US2018/021592 patent/WO2018165460A1/en not_active Ceased
- 2018-03-08 US US15/915,284 patent/US11045482B2/en active Active
- 2018-03-08 AU AU2018230429A patent/AU2018230429B2/en active Active
- 2018-03-08 EP EP18763240.1A patent/EP3592358A4/en active Pending
- 2018-03-08 MX MX2019010732A patent/MX2019010732A/es unknown
- 2018-03-08 JP JP2019548370A patent/JP7564620B2/ja active Active
-
2022
- 2022-04-21 JP JP2022070027A patent/JP2022090003A/ja not_active Withdrawn
-
2024
- 2024-03-28 JP JP2024053332A patent/JP2024074854A/ja not_active Withdrawn
-
2026
- 2026-04-03 JP JP2026061808A patent/JP2026099911A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014240408A5 (cg-RX-API-DMAC7.html) | ||
| JP2018184417A5 (cg-RX-API-DMAC7.html) | ||
| RU2013102398A (ru) | Лечение рака крови | |
| TW200500355A (en) | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases | |
| MXPA05012155A (es) | Metodos y composiciones que utilizan compuestos inmunomoduladores para el tratamiento y manejo de canceres y otras enfermedades. | |
| CA2939464A1 (en) | Use of anti-ccr5 antibodies in graft versus host disease | |
| WO2003097052A3 (en) | Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| MX2019013279A (es) | Metodos de tratamiento del sindrome de doose utilizando fenfluramina. | |
| MY199903A (en) | Combination therapy with controlled-release cnp agonists | |
| EA202191079A1 (ru) | Способы лечения синдрома ретта с применением фенфлурамина | |
| JP2012193216A5 (cg-RX-API-DMAC7.html) | ||
| MY150682A (en) | Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
| JP2015505564A5 (cg-RX-API-DMAC7.html) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2016507493A5 (cg-RX-API-DMAC7.html) | ||
| JP2020512361A5 (cg-RX-API-DMAC7.html) | ||
| JP2022116304A (ja) | 血液がんの治療のためのPPARγアゴニスト | |
| JP2017537927A5 (cg-RX-API-DMAC7.html) | ||
| JPWO2020250915A5 (cg-RX-API-DMAC7.html) | ||
| MX2020011295A (es) | Tratamiento de dermatitis atopica. | |
| JP2016515621A5 (cg-RX-API-DMAC7.html) | ||
| JP2022546456A5 (cg-RX-API-DMAC7.html) | ||
| JP2018502089A5 (cg-RX-API-DMAC7.html) | ||
| MX2025011882A (es) | Metodos de tratamiento del cancer con un agonista del receptor de linfotoxina beta |